Alnylam: Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients. Based in United States.
⚠️ This profile was automatically generated by the AYA bot. Information may be inaccurate. Claim this profile to correct and certify your data.
Identification
* This score measures how readable the company is by AIs (ChatGPT, Gemini, Claude...). The higher the score, the more visible and recommendable the company is.
Public Key (AYA ID)
269dbfe0-d33f-5f82-aced-2238825b1c31
Issue date
2 juin 2026
Validity
—
Last modified: 2 juin 2026
Semantic Data (AI)
"Alnylam has pioneered RNAi therapeutics, an innovative approach to gene silencing. We are driven by science and committed to developing transformational medicines for patients."
Indexed Keywords
Supported Protocols
- ✓ JSON-LD Structure
- ✓ ASR v3.0 Standard
Related entities
Other entities in the same sector or country
Secured by AYO Consensus • Swiss Hosting